ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 3B 6B 9B FY07: 3.9B FY08: 4.1B FY09: 4.1B FY10: 4.2B FY16: 7.7B FY17: 7.8B FY18: 7.9B FY19: 8B FY20: 6.1B FY21: 6.8B FY22: 6.9B FY23: 7.4B FY24: 7.7B FY25: 8.2B FY08 FY10 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 1.5B 3B 4.5B FY07: 3B FY08: 3.1B FY09: 3.1B FY10: 3.2B FY11: 3.3B FY12: 3.3B FY13: 3.3B FY14: 3.4B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14

Operating Income Annual

0 500M 1B 1.5B FY07: 1.1B FY08: 1.1B FY09: 1B FY10: 916.7M FY11: 1B FY12: 1B FY13: 1.1B FY14: 1B FY15: 467.3M FY16: 821.1M FY17: 799.3M FY18: 33.8M FY19: 1.1B FY20: 83.1M FY21: 860.3M FY22: 696.3M FY23: 1.3B FY24: 1.3B FY25: 1.1B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-700M 0 700M 1.4B 2.1B FY07: 773.2M FY08: 848.6M FY09: 717.4M FY10: 596.9M FY11: 760.8M FY12: 755M FY13: 780.4M FY14: 720.3M FY15: 147M FY16: 305.9M FY17: 1.8B FY18: -379.2M FY19: 1.1B FY20: -138.9M FY21: 401.6M FY22: 231.4M FY23: 1B FY24: 903.8M FY25: 705.1M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 900M 1.8B 2.7B FY07: 875.9M FY08: 997.3M FY09: 990.7M FY10: 1B FY16: 2.4B FY17: 2.1B FY18: 2.3B FY19: 2.3B FY20: 1.8B FY21: 2B FY22: 2B FY23: 2.1B FY24: 2.2B FY25: 2.5B FY08 FY10 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 600M 1.2B 1.8B FY07: 1.1B FY08: 1B FY09: 1.1B FY10: 1.2B FY11: 1.2B FY12: 1.2B FY13: 963.1M FY14: 1.1B FY15: 849.8M FY16: 1.6B FY17: 1.6B FY18: 1.7B FY19: 1.6B FY20: 1.2B FY21: 1.5B FY22: 1.4B FY23: 1.6B FY24: 1.5B FY25: 1.7B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 600M 1.2B 1.8B FY07: 891.7M FY08: 788.1M FY09: 1B FY10: 1.1B FY11: 1.1B FY12: 1B FY13: 863.1M FY14: 915.6M FY15: 682.1M FY16: 1.4B FY17: 1.4B FY18: 1.6B FY19: 1.4B FY20: 1.1B FY21: 1.4B FY22: 1.2B FY23: 1.3B FY24: 1.3B FY25: 1.5B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 90M 180M 270M FY07: 237.5M FY08: 228.3M FY09: 215.8M FY10: 201.1M FY11: 188.7M FY12: 176M FY13: 171.8M FY14: 171.7M FY15: 189.8M FY16: 202.4M FY17: 203.7M FY18: 203.5M FY19: 206.7M FY20: 207M FY21: 210.4M FY22: 210.3M FY23: 209.7M FY24: 203.9M FY25: 198.7M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.50 0.00 3.50 7.00 10.50 Q4 '08: 3.72 Q1 '09: 3.60 Q2 '09: 3.59 Q3 '09: 3.34 Q4 '09: 3.33 Q1 '10: 3.43 Q2 '10: 3.27 Q3 '10: 3.53 Q4 '10: 2.97 Q1 '11: 3.04 Q2 '11: 3.28 Q3 '11: 3.33 Q4 '11: 4.02 Q1 '12: 4.11 Q2 '12: 4.27 Q3 '12: 4.28 Q4 '12: 4.29 Q1 '13: 4.40 Q2 '13: 4.07 Q3 '13: 3.95 Q4 '13: 4.43 Q1 '14: 4.44 Q2 '14: 4.58 Q3 '14: 4.69 Q4 '14: 4.22 Q1 '15: 3.92 Q2 '15: 1.89 Q2 '16: 1.11 Q3 '16: 1.78 Q4 '16: 1.50 Q1 '17: 2.43 Q2 '17: 3.49 Q3 '17: 3.19 Q4 '17: 8.88 Q1 '18: 8.26 Q2 '18: 8.26 Q3 '18: 8.57 Q4 '18: -1.88 Q1 '19: -1.53 Q2 '19: -1.78 Q3 '19: -0.49 Q4 '19: 5.47 Q1 '20: 1.81 Q2 '20: 0.16 Q1 '21: 2.69 Q2 '21: 4.36 Q3 '21: 3.89 Q4 '23: 4.88 Q1 '24: 4.61 Q2 '24: 4.79 Q3 '24: 5.25 Q4 '24: 4.44 Q1 '25: 4.51 Q2 '25: 4.10 Q3 '25: 4.03 Q4 '25: 3.55 Q1 '26: 3.86 Q2 '26: 4.12 Q1 '09 Q1 '11 Q1 '13 Q1 '15 Q4 '17 Q4 '19 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.